Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGP-20712 is a selective β 1-adrenoceptor antagonist with an IC50 of 0.7 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 350.00 | |
5 mg | In stock | $ 828.00 | |
10 mg | In stock | $ 1,130.00 | |
25 mg | In stock | $ 1,590.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 | |
500 mg | In stock | $ 4,900.00 |
Description | CGP-20712 is a selective β 1-adrenoceptor antagonist with an IC50 of 0.7 nM. |
Targets&IC50 | β1-adrenoceptor:0.7 nM, β2-adrenoceptor:6700 nM |
In vitro |
In brown adipocytes, CGP-20712 (1 μM) significantly inhibited UCP1 gene expression induced by NE. However, CGP-20712 had no effect on lipolysis. These results suggested that β1-adrenoceptor mediated UCP1 gene expression.[4] In neocortical membranes, CGP 20712 exhibited affinity for β1-adrenoceptor and β2-adrenoceptor with IC50 values of 0.7 and 6700 nM, respectively.[1] |
In vivo | CGP 20712 (a selective beta 1-adrenergic receptor antagonist) (5 mg/kg; Pretreatment of 8-day-old rats) did not change the plasma ACTH response to insulin injection.[3] |
Synonyms | UNII-SIO2UEZ19H, CGP 20712 |
Molecular Weight | 494.46 |
Formula | C23H25F3N4O5 |
CAS No. | 137888-49-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP-20712 137888-49-4 GPCR/G Protein Neuroscience Adrenergic Receptor UNII-SIO2UEZ19H CGP 20712 CGP20712 inhibitor inhibit